Decentralized Trial Technology Resources

1. Industry Perspectives On Clinical Technologies 6/14/2023

   Take note of the characteristics experts should consider when selecting an IRT provider, what sponsors are using more than one CTMS solution, the future of EDC, and more.

2. Facts And Misconceptions About ePRO Cost-Effectiveness 11/17/2022

   This eBook will focus on the misconceptions around the cost-effectiveness of electronic patient-reported outcomes (ePRO) and also share key points to consider when evaluating various ePRO solutions.

3. Recommendations For Optimizing Televisits 6/6/2022

   Discover the pros and cons of telehealth visits and what can be done to continuously improve them.

4. Gradually Investing In Direct Data Capture Is Inevitable 2/2/2023

   Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”

5. RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk 9/26/2022

   This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.

6. 5 Essential Capabilities For Decentralized Clinical Trials 2/3/2025

   Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.

7. The Right EDC Solution For Oncology Trials 5/19/2023

   Oncology clinical trials can be very complex, as are their data management needs. Understand why selecting the right EDC is crucial for managing them efficiently while providing compassionate care.

8. How eConsent Can Help Legally Authorized Representatives 6/22/2022

   Software vendors often forget to think about the needs of LARs, even though they play a vital role in clinical trials. Explore three ways eConsent can help LARs complete the informed consent process.

9. Our Unified Platform Serves As eSource For COVID Treatment Trial 6/17/2024

   Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.

10. How Small And Mid-Sized Biopharmaceutical Companies Can Easily Achieve Digital Innovation For Their Clinical Data 7/12/2022

    Discover how forward- thinking life science companies are defining their vision and looking for like-minded partners to execute information technology.